416241341	416241341	CD	B-NP	O
|	|	NN	I-NP	O
RMCH	RMCH	NN	I-NP	O
|	|	NN	I-NP	O
32268742	32268742	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9884910	9884910	CD	B-NP	O
|	|	CC	I-NP	O
9/17/2006	9/17/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PYLMETHRIGIS	PYLMETHRIGIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/6/2006	4/6/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/2006	5/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
DECULUS	DECULUS	NNP	B-NP	O
,	,	,	O	O
JOE	JOE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Inability	Inability	NN	B-NP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	O
overdose	overdose	NN	I-NP	O
,	,	,	O	O
comes	come	VBZ	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
flank	flank	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
low-grade	low-grade	JJ	B-NP	O
temperatures	temperature	NNS	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
down	down	RP	B-PRT	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
to	to	TO	B-PP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
just	just	RB	B-NP	O
DC	DC	NN	I-NP	B-cell_type
'd	'd	MD	B-VP	O
6/21/06	6/21/06	CD	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
grew	grow	VBD	B-VP	O
Proteus	Proteus	NN	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
Cipro	Cipro	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
point	point	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
costophrenic	costophrenic	JJ	I-NP	O
angle	angle	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
of	of	IN	B-PP	O
Ceptaz	Ceptaz	NN	B-NP	B-protein
,	,	,	O	O
fluids	fluid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
GMS	GMS	NN	B-NP	B-protein
floor	floor	NN	I-NP	I-protein
on	on	IN	B-PP	O
9/18/06	9/18/06	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Enalapril	Enalapril	NNP	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Cefradox	Cefradox	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
hydroxyzine	hydroxyzine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Monday	Monday	NNP	B-NP	O
and	and	CC	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

if	if	IN	B-SBAR	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
90	90	CD	I-NP	O
units	unit	NNS	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
99.2	99.2	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
119/58	119/58	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
98	98	CD	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
sit	sit	VB	I-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
oriented	oriented	JJ	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Drowsy	Drowsy	NNP	B-NP	O
JANCZAK	JANCZAK	NNP	I-NP	O
,	,	,	O	O
YONG	YONG	NNP	B-NP	O
Neck	Neck	NNP	I-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
below	below	IN	B-PP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

COR	COR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
1/6	1/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Mild	Mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
lower	low	JJR	I-NP	I-protein
quadrant	quadrant	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
guarding	guarding	NN	I-NP	O
or	or	CC	I-NP	O
rebound	rebound	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
pulse	pulse	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DTR	DTR	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
sensation	sensation	NN	B-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
touch	touch	NN	I-NP	O
in	in	IN	B-PP	O
feet	foot	NNS	B-NP	O
,	,	,	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
lift	lift	VB	I-VP	O
legs	leg	NNS	B-NP	O
against	against	IN	B-PP	O
gravity	gravity	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Pertinent	Pertinent	JJ	B-NP	O
positive	positive	JJ	I-NP	O
,	,	,	I-NP	O
potassium	potassium	NN	I-NP	O
5.4	5.4	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
69	69	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.3	2.3	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
214	214	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
32.3	32.3	CD	I-NP	I-protein
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
,	,	,	O	O
50-60	50-60	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cloudy	cloudy	NN	B-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
specification	specification	NN	B-NP	O
in	in	IN	B-PP	O
prior	prior	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
Proteus	Proteus	NNP	B-NP	O
mirabilis	mirabili	VBZ	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
cephalosporins	cephalosporin	NNS	B-NP	O
and	and	CC	O	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
9/18/06	9/18/06	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
10/10	10/10	CD	B-NP	O
bilateral	bilateral	JJ	I-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
required	require	VBD	B-VP	O
change	change	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
medication	medication	NN	I-NP	O
from	from	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
to	to	TO	B-PP	O
Dilaudid	Dilaudid	NNP	B-NP	O
,	,	,	O	O
first	first	JJ	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
doses	dose	VBZ	B-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
were	be	VBD	B-VP	O
allowed	allow	VBN	I-VP	O
with	with	IN	B-PP	O
1-2	1-2	CD	B-NP	O
mg	mg	NN	I-NP	O
then	then	RB	B-ADVP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
augmented	augment	VBN	I-VP	O
to	to	TO	I-VP	O
p.r.n.	p.r.n.	VB	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
2-4	2-4	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
pain	pain	NN	I-NP	O
consult	consult	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
changed	change	VBD	B-VP	O
Neurontin	Neurontin	NN	B-NP	B-protein
to	to	TO	B-PP	O
Lyrica	Lyrica	NNP	B-NP	O
100	100	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
pain	pain	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
improved	improve	VBD	B-VP	O
tremendously	tremendously	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
using	use	VBG	I-VP	O
the	the	DT	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
plateau	plateau	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
usages	usage	NNS	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
Dilaudid	Dilaudid	VBD	B-VP	O
p.o.	p.o.	FW	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
next	next	JJ	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

UTI	UTI	LS	B-LST	O
:	:	:	O	O
During	During	IN	B-PP	O
prehospital	prehospital	NN	B-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
________	________	VBD	B-VP	O
Bactrim	Bactrim	NN	B-NP	O
and	and	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
put	put	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
2	2	CD	I-NP	O
g	g	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
intravenously	intravenously	RB	B-ADVP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
improved	improve	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
or	or	CC	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
flank	flank	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
has	have	VBZ	B-VP	O
clinically	clinically	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
intravenous	intravenous	JJ	B-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
another	another	DT	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
3/11/06	3/11/06	CD	B-NP	O
.	.	.	O	O

FUTURE	FUTURE	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
Neuropathic	Neuropathic	JJ	B-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetic	diabetic	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lyrica	Lyrica	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
p.r.n.	p.r.n.	FW	B-NP	O
p.o.	p.o.	FW	I-NP	O
Per	Per	NNP	I-NP	O
pain	pain	NN	I-NP	O
consult	consult	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	I-VP	O
change	change	VB	I-VP	O
her	her	PRP$	B-NP	O
antidepressant	antidepressant	NN	I-NP	O
Prozac	Prozac	NN	I-NP	O
to	to	TO	B-PP	O
Cymbalta	Cymbalta	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
taper	taper	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Prozac	Prozac	NNP	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Cymbalta	Cymbalta	NN	B-NP	B-protein
.	.	.	O	O

First	First	RB	B-ADVP	O
start	start	VBP	B-VP	O
with	with	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Prozac	Prozac	NN	B-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Cymbalta	Cymbalta	NN	B-NP	B-protein
then	then	RB	B-VP	O
gradually	gradually	RB	I-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
Cymbalta	Cymbalta	NNP	I-NP	O
and	and	CC	O	O
decrease	decrease	VB	B-VP	O
the	the	DT	B-NP	O
Prozac	Prozac	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
30-20	30-20	CD	B-NP	O
,	,	,	I-NP	O
20-30	20-30	CD	I-NP	O
,	,	,	I-NP	O
10-40	10-40	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
finally	finally	RB	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
Cymbalta	Cymbalta	NN	I-NP	O
.	.	.	O	O

Cymbalta	Cymbalta	NNP	B-NP	O
has	have	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
neuropathic	neuropathic	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
largely	largely	RB	B-ADVP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
measures	measure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
pain	pain	NN	B-NP	O
consult	consult	NN	I-NP	O
setup	setup	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Branco	Branco	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Kee	Kee	NNP	I-NP	O
Te	Te	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
8/11/06	8/11/06	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
is	be	VBZ	B-VP	O
morbid	morbid	JJ	B-NP	O
obese	obese	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BMI	BMI	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
which	which	WDT	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
her	her	PRP$	B-NP	O
abilities	ability	NNS	I-NP	O
to	to	TO	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
herself	herself	PRP	B-NP	O
,	,	,	O	O
cleaning	cleaning	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
toilet	toilet	NN	I-NP	O
,	,	,	O	O
mobilization	mobilization	NN	B-NP	O
is	be	VBZ	B-VP	O
difficult	difficult	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
drastic	drastic	JJ	B-NP	O
dietetic	dietetic	JJ	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
programs/consider	programs/consider	NN	I-NP	O
GI	GI	NN	I-NP	O
surgical	surgical	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
appetite	appetite	NN	B-NP	O
and	and	CC	O	O
help	help	NN	B-VP	O
losing	lose	VBG	I-VP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATION	MEDICATION	NN	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
once	once	RB	B-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
check	check	NN	B-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
ceftriaxone	ceftriaxone	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
once	once	RB	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-VP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
2-4	2-4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	IN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Fleet	Fleet	NNP	B-NP	O
Enema	Enema	NNP	I-NP	O
one	one	CD	I-NP	O
bottle	bottle	NN	I-NP	O
p.r.	p.r.	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
70	70	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
beware	beware	NN	B-NP	O
of	of	IN	B-PP	O
hypoglycemic	hypoglycemic	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
Lantus	Lantus	NNP	B-NP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	B-DNA
to	to	TO	I-NP	I-DNA
70	70	CD	I-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
over	over	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
as	as	IN	B-PP	O
per	per	IN	B-PP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
as	as	IN	B-PP	O
per	per	IN	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
quick	quick	JJ	B-ADJP	O
dissolve	dissolve	VBP	B-VP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
Lyrica	Lyrica	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-6178092	6-6178092	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GODOY	GODOY	NNP	B-NP	O
,	,	,	O	O
BUCK	BUCK	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CALIXTRO	CALIXTRO	NNP	B-NP	O
,	,	,	O	O
DAREN	DAREN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4258162	4258162	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O

